Apogee Therapeutics was founded by a team of experienced life sciences entrepreneurs, veteran drug developers, and scientific researchers aiming to revolutionize the treatment landscape for immunological and inflammatory diseases. Their shared vision centered on leveraging advanced protein engineering to overcome the pharmacokinetic limitations of traditional antibody therapies.